Category: Companion Diagnostics
Global Companion Diagnostics
-
The 2025-2030 World Outlook for Companion Diagnostics Assay Kits and Reagents
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Growth (Status and Outlook) 2024-2030
... was valued at US$ 9383.3 million in 2023. With growing demand in downstream market, the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) is forecast to a readjusted size of US$ 25340 million by 2030 ... Read More
-
Companion Diagnostics (CDx) Market Report 2024-2034
... underlying dynamics better. It will be useful for companies that want to expand into different industries or their existing operations in a new region. Technological Improvements in the CDx Market The market for CDx is ... Read More
-
The World Market for Veterinary Diagnostics, 7th Edition
... on swift, reliable, and accurate methods, facilitating informed diagnoses. Despite various challenges, the veterinary diagnostics market has shown consistent growth and is forecasted to continue on this trajectory. This sector presents a rapidly expanding market ... Read More
-
Companion Diagnostics Market by Technology (Immunohistochemistry, In Situ Hybridization, Next-Generation Sequencing), Indication (Breast Cancer, Colorectal Cancer, Leukemia), End-User - Global Forecast 2024-2030
... and expected to reach USD 2.92 billion in 2024, at a CAGR 11.55% to reach USD 5.63 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Companion Diagnostics Market. ... Read More
-
Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Companion Diagnostics), Application (CNS, Immunology, Oncology), End-User, Deployment - Global Forecast 2024-2030
... expected to reach USD 75.70 billion in 2024, at a CAGR 11.22% to reach USD 143.43 billion by 2030. Global Precision Medicine Market Precision medicine refers to the strategy of tailoring disease prevention and treatment ... Read More
-
Global Companion Diagnostics Market Research Report 2024(Status and Outlook)
... exhibiting a CAGR of 13.20% during the forecast period. This report provides a deep insight into the global Companion Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market ... Read More
-
Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Research Report 2024(Status and Outlook)
... in 2023 and is projected to reach USD 9612.04 million by 2029, exhibiting a CAGR of 14.70% during the forecast period. This report provides a deep insight into the global Pharmacogenomics Technology and Theranostics and ... Read More
-
Global Companion Diagnostics for Oncology Market Research Report 2024(Status and Outlook)
... information about the effective use of a corresponding therapeutic product by analyzing the genetic material. With the rise in cancer prevalence, coupled with increasing strategic initiatives, there has been a huge demand for companion diagnostics ... Read More
-
Companion Diagnostics Global Market Report 2024
... Cancer; Colorectal Cancer; Leukemia; Melanoma4) By End-User: Pharmaceutical And Biopharmaceutical Companies; Reference Laboratories; Contract Research OrganizationsCovering: F Hoffmann-La Roche Ltd.; Agilent Technologies Inc.; Qiagen NV; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc. Companion Diagnostics Global ... Read More
-
Cancer Diagnostics Global Market Report 2024
... Cancer; Colorectal Cancer; Pancreatic Cancer; Ovarian Cancer; Melanoma4) By End-User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals Covering: Abbott Laboratories; Becton Dickinson and Company; Hologic; GE Healthcare Ltd.; Thermo Fisher Scientific Cancer Diagnostics Global Market Report ... Read More
-
Precision Medicine Market Report Product (Consumables, Instruments, Services), Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, and Others), Application (Oncology, Central Nervous System (CNS), Immunology, Respiratory Medicine, Infections, and Others), End User (Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, and Others), and Region 2023-2028
... (Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, and Others), and Region 2023-2028 The global precision medicine market size reached US$ 68.1 Billion in 2022. Looking forward, IMARC Group expects the ... Read More
-
Multiplex Assay Market By Type (Protein Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Cell-based Multiplex Assays), By Product (Reagents and Consumables, Instruments and Accessories, Software and Services), By Application (Clinical Diagnostics, Research and Development, Companion Diagnostics), By End User (Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical and Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Diagnostics), By End User (Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical and Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2023-2032 The Multiplex Assay Market was valued at $3.6 billion in 2022 and is estimated to ... Read More
-
30-Country IVD Market Atlas
... of over $120 billion. With less than half that revenue earned in the United States, an assessment of regional and country IVD markets is needed for successful business planning. Kalorama’s 30 Country IVD Market Atlas ... Read More
-
Global Fluorescent in Situ Hybridization (FISH) Probe Market: (by Product, Technology, End User, Application, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)
... cytogenetic technique known as Fluorescent in Situ Hybridization (FISH) to visualize genetic material. They are used to spot chromosomal structural and numerical anomalies, monitor the effects of therapeutic drugs, and find unusual genetic illnesses. FISH ... Read More
-
Liquid Biopsy Market - Global Outlook & Forecast 2023-2028
... a Companion Diagnostics As liquid biopsy technologies continue to advance, their role as companion diagnostics is expanding rapidly. The non-invasive nature, ability to capture tumor heterogeneity and dynamics, early detection of MRD, real-time treatment response ... Read More
-
Global Clinical Oncology Next Generation Sequencing Market Size study & Forecast, by Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing) by Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), by Application (Screening, Companion Diagnostics, Others), by End Use (Hospitals, Clinics, Laboratories) and Regional Analysis, 2023-2030
... Companion Diagnostics, Others), by End Use (Hospitals, Clinics, Laboratories) and Regional Analysis, 2023-2030 Global Clinical Oncology Next Generation Sequencing Market is valued at approximately USD 370.0 million in 2022 and is anticipated to grow with ... Read More
-
Companion Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product and Services (Kits and Reagents, Assays, Software, and Services), By Technology (PCR, NGS, In-Situ Hybridization, Immunohistochemistry, and Others), By Disease Indication (Oncology, Neurology, Cardiology, Infectious Diseases, and Others), By Application (In-Vitro Diagnostics, Drug Discovery, and Others), By End User (Pharmaceutical & Biotechnology Companies, Research Laboratories, Contract Research Organization, and Others), By Region and Competition
... period with a CAGR of 6.58 through 2028. Contraceptive pills, also known as birth control medications, are specifically designed to prevent pregnancy and regulate birth rates. These medications are synthetically formulated using a combination of ... Read More
-
Next-Generation Gynecological Cancer Diagnostics Global Market Report 2023 Including: 1) By Cancer Type: Cervical Cancer; Ovarian Cancer; Uterine Cancer; Vaginal Cancer; Vulvar Cancer 2) By Function: Therapeutic Monitoring; Companion Diagnostics; Prognostics; Cancer Screening; Risk Analysis 3) By Technology: Next-Generation Sequencing; qPCR And Multiplexing; Lab-on- a- chip (LOAC) And Reverse Transcriptase-PCR (RT-PCR); Protein Microarrays; DNA Microarrays 4) By Application: Biomarker Development; CTC Analysis; Proteomic Analysis; Epigenetic Analysis; Genetic Analysis 5) By End User: Hospitals and Ambulatory Centers; Diagnostic Laboratories; Academic and Research Institutes Covering: F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Novartis AG; Thermo Fisher Scientific Inc.; Abbott Laboratories
... Technology: Next-Generation Sequencing; qPCR And Multiplexing; Lab-on- a- chip (LOAC) And Reverse Transcriptase-PCR (RT-PCR); Protein Microarrays; DNA Microarrays4) By Application: Biomarker Development; CTC Analysis; Proteomic Analysis; Epigenetic Analysis; Genetic Analysis5) By End User: Hospitals and ... Read More
-
Single-Use Upstream Bioprocessing Technology Market by Type of Product (Single-use Bioreactors, Single-use Mixers, Single-use Media Bags, Single-use Filters, Single-use Sampling Systems, Single-use Connectors and Others), Scale of Operation (Preclinical / Clinical and Commercial) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin-America, Middle East and North Africa and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
... Geographical Regions (North America, Europe, Asia-Pacific, Latin-America, Middle East and North Africa and Rest of the World): Industry Trends and Global Forecasts, 2022-2035 INTRODUCTION Over the past few years, the improved understanding of molecular mechanisms ... Read More
-
Companion Diagnostics Market Forecasts to 2030 – Global Analysis By Product (Kits & Reagents and Assays), Indication (Leukaemia, Melanoma, Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases and Other Indications), Technology, End User and By Geography
... According to Stratistics MRC, the Global Companion Diagnostics Market is accounted for $7.24 billion in 2023 and is expected to reach $18.81 billion by 2030 growing at a CAGR of 14.6% during the forecast period. ... Read More
-
Global Companion Diagnostics Market - 2023-2030
... companion diagnostics market is expected to exhibit a CAGR of 12.2% during the forecast period (2023-2030). The trends in the global companion diagnostic market include the rising utilization of companion diagnostics, the collaborative efforts between ... Read More
-
Companion Diagnostics Development Services Market (2nd Edition): Distribution by Type of Service Offered (Feasibility Studies, Assay Development, Analytical Validation, Clinical Validation and Manufacturing), Analytical Technique Used (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry / in situ Hybridization (IHC / ISH), Liquid Biopsy and Others), Therapeutic Areas (Oncological and Non-oncological) and Key Geographies (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
... / in situ Hybridization (IHC / ISH), Liquid Biopsy and Others), Therapeutic Areas (Oncological and Non-oncological) and Key Geographies (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035 INTRODUCTION ... Read More
-
2023 Global Forecast for Pharmacogenomics Technology/Theranostics/Companion Diagnostics (Cdx) Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End Users (Diagnostic laboratories, Research Institute) - Global Forecast to 2028
... reach USD 4.7 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 7.4% during the forecast period of 2023 to 2028. Market growth is largely driven by increased prevalence of cancer ... Read More
Research Assistance
